Cathepsin D in ovarian cancer:: prognostic value and correlation with p53 expression and microvessel density

被引:51
|
作者
Lösch, A
Schindl, M
Kohlberger, P
Lahodny, J
Breitenecker, G
Horvat, R
Birner, P
机构
[1] Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Gynecol & Obstet, A-1090 Vienna, Austria
[3] Hosp St Polten, Dept Gynecol & Obstet, A-3100 St Polten, Austria
关键词
cathepsin D; ovarian cancer; prognosis; p53; angiogenesis;
D O I
10.1016/j.ygyno.2003.11.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Overexpression of ubiquitous lysosomal aspartyl protease cathepsin D (CD) is involved in the progression of cancer. This study investigates the prognostic value and the association of cathepsin D expression with clinicopathological parameters, p53 expression, and angiogenesis in ovarian cancer. Methods. Cathepsin D was determined immunohistochemically in 43 ovarian tumors of low malignant potential (LMP) and 80 invasive tumors FIGO stage I-IV. Results were correlated with clinicopathological characteristics, p53, and microvessel density (MVD). Survival analysis of cathepsin D expression and MVD was performed in invasive tumors. Results. Epithelial tumor cathepsin D expression was more common in LMP tumors (65.1%) compared to invasive tumors (43.7%; P = 0.02). In LMP tumors, stromal cathepsin D was associated with mucinous tumors (P = 0.01), whereas in invasive tumors, epithetial cathepsin D expression was associated with clear cell tumors (P = 0.003). Invasive tumor cathepsin D had a negative relation to p53 expression. In LMP tumors, stromal cathepsin D correlated with microvessel density (P = 0.03). Stromal cathepsin D expression was an independent prognostic factor for disease-free survival (DFS) in patients with invasive cancer (P = 0.03, Cox regression), while cathepsin D expression missed to be of prognostic value for overall survival (OS) in invasive ovarian cancer. MVD had no influence on survival in invasive ovarian cancer (P > 0.05). Conclusion. Our study demonstrates a prognostic value of cathepsin D expression in invasive ovarian cancer, while cathepsin D expression in LMP rumors seems to be linked to angiogenesis. The relation among cathepsin D, p53 expression, and angiogenesis demonstrates biological differences between invasive ovarian cancer and LMP tumors. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 50 条
  • [41] The prognostic value of UHRF-1 and p53 in gastric cancer
    Babacan, Nalan A.
    Egilmez, Hatice Reyhan
    Yucel, Birsen
    Parlak, Ilknur
    Seker, Mehmet Metin
    Kacan, Turgut
    Bahceci, Aykut
    Cihan, Sener
    Akinci, Bulent
    Eriten, Berna
    Kilickap, Saadettin
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2016, 22 (01) : 25 - 29
  • [42] Prognostic Value of p53 Expression Intensity in Urothelial Cancers
    Qamar, Samina
    Inam, Qazi Adil
    Ashraf, Sobia
    Khan, M. Safdar
    Khokhar, M. Abbas
    Awan, Nukhbatullah
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2017, 27 (04): : 232 - 236
  • [43] RELATION BETWEEN MICROVESSEL DENSITY, EXPRESSION OF KI-67 AND P53 WITH CLINICOPATHOLOGIC PARAMETERS AND PATIENT PROGNOSIS IN PROSTATE CANCER
    Acar, Cenk
    Sozen, Sinan
    Erdem, Ozlem
    Gurocak, Serhat
    Yilmaz, Gurdal
    Bozkirli, Ibrahim
    TURKISH JOURNAL OF UROLOGY, 2006, 32 (04): : 478 - 485
  • [44] p53 and microvessel density in primary resection specimens of superficial bladder cancer
    Reiher, F
    Ozer, O
    Pins, M
    Jovanovic, BD
    Eggener, S
    Campbell, SC
    JOURNAL OF UROLOGY, 2002, 167 (03) : 1469 - 1474
  • [45] Prognostic value of p53 protein expression in squamous cell carcinoma of the esophagus
    Monges, GM
    Seitz, JF
    Giovannini, MF
    Gouvernet, JM
    Torrente, MAM
    Hassoun, JA
    CANCER DETECTION AND PREVENTION, 1996, 20 (01): : 63 - 67
  • [46] Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer
    Lösch, A
    Tempfer, C
    Kohlberger, P
    Joura, EA
    Denk, M
    Zajic, B
    Breitenecker, G
    Kainz, C
    BRITISH JOURNAL OF CANCER, 1998, 78 (02) : 205 - 209
  • [47] Prognostic value of p53 protein expression for patients with gastric cancer – a multivariate analysis
    Y Maehara
    M Tomoda
    S Hasuda
    A Kabashima
    E Tokunaga
    Y Kakeji
    K Sugimachi
    British Journal of Cancer, 1999, 79 : 1255 - 1261
  • [48] PROGNOSTIC VALUE OF CATHEPSIN-D EXPRESSION IN FEMALE BREAST-CANCER
    AALTONEN, M
    LIPPONEN, P
    KOSMA, VM
    AALTOMAA, S
    SYRJANEN, K
    ANTICANCER RESEARCH, 1995, 15 (03) : 1033 - 1037
  • [49] Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
    Hofstetter, G.
    Berger, A.
    Schuster, E.
    Wolf, A.
    Hager, G.
    Vergote, I.
    Cadron, I.
    Sehouli, J.
    Braicu, E. I.
    Mahner, S.
    Speiser, P.
    Marth, C.
    Zeimet, A. G.
    Ulmer, H.
    Zeillinger, R.
    Concin, N.
    BRITISH JOURNAL OF CANCER, 2011, 105 (10) : 1593 - 1599
  • [50] Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients
    Korkolis, DP
    Tsoli, E
    Fouskakis, D
    Yiotis, J
    Koullias, GJ
    Giannopoulos, D
    Papalambros, E
    Nikiteas, NI
    Spiliopoulou, CA
    Patsouris, E
    Asimacopoulos, P
    Gorgoulis, VG
    ANTICANCER RESEARCH, 2004, 24 (3B) : 2061 - 2068